BioCentury
ARTICLE | Strategy

Sorting out the bone markers

November 13, 1995 8:00 AM UTC

Noteworthy

The proliferation of FDA-approved tests of bone resorption this year has made it increasingly difficult to differentiate the products and their purposes, a problem that will only increase over time. The latest approvals are for two Pyrilinks urine tests developed by Metra Biosystems Inc. (MTRA). ...